Minimal Clinically Important Differences in 6-Minute Walk Test in Patients With HFrEF and Iron Deficiency

Background: The 6-minute walk test (6MWT) is widely used to measure exercise capacity; however, the magnitude of change that is clinically meaningful for individuals is not well established in heart failure with reduced ejection fraction (HFrEF). Objective: To calculate the minimal clinically important difference (MCID) for change in exer-cise capacity in the 6MWT in iron-deficient populations with HFrEF. Methods: In this pooled secondary analysis of the FAIR-HF and CONFIRM-HF trials, mean changes in the 6MWT from baseline to weeks 12 and 24 were calculated and calibrated against the Patient Global Assessment (PGA) tool (clinical anchor) to derive MCIDs in improvement and deterioration. Results: Of 760 patients included in the 2 trials, 6MWT and PGA data were available for 680 (89%) and 656 (86%) patients at weeks 12 and 24, respectively. The mean 6MWT distance at baseline was 281 (SIC) 103 meters. There was a modest correlation between changes in 6MWT and PGA from baseline to week 12 (r = 0.31; P< 0.0001) and week 24 (r = 0.43; P< 0.0001). Respec-tive estimates (95% confidence intervals) of MCID in 6MWT at weeks 12 and 24 were 14 meters (5;23) and 15 meters (3;27) for a little improvement (vs no change), 20 meters (10;30) and 24 meters (12;36) for moderate improvement vs a little improvement,,-11 meters (-32;9.2) and-31 meters (-53;-8) for a little deterioration (vs no change), and-84 meters (-144;-24) and-69 meters (-118;-20) for moderate deterioration vs a little deterioration. Conclusions: The MCID for improvement in exercise capacity in the 6MWT was 14 meters-15 meters in patients with HFrEF and iron deficiency. These MCIDs can aid clinical interpretation of study data. (J Cardiac Fail 2023;29:760-770)

Automated summary

This study aims to calculate the minimal clinically important difference (MCID) for change in exercise capacity in the 6-minute walk test (6MWT) in iron-deficient populations with heart failure and reduced ejection fraction (HFrEF). Through secondary analysis of two trials, the MCIDs for improvement and deterioration in the 6MWT at 12 and 24 weeks were determined.